
Beni Surpin
Beni Surpin is a partner in Goodwin’s Life Sciences group, where he focuses on global licensing and collaboration agreements and other intellectual property and commercial transactions. He counsels US and international companies in the life sciences, medical device, digital health, and healthtech sectors on complex legal and business issues involving the development, transfer, and commercialization of technology.
Beni works closely with clients from proof of concept through full commercialization to set strategic direction, structure commercial relationships, and negotiate transactions that provide access to new technologies and support the development and expansion of their products and services. He also advises public and private companies on maximizing value and revenue from their intellectual property and technology portfolios.
Beni’s experience spans licensing and collaboration agreements, technology transfers, acquisitions, joint ventures, strategic partnerships and alliances, and transactions involving service-based platforms. He also advises on clinical, research and development, manufacturing, supply, distribution, and services agreements. His broader experience encompasses corporate lifecycle matters and equity and debt financing, supporting emerging growth companies, middle-market businesses, and multinational corporations in their strategic planning, development, and growth.
Among his professional recognitions, Chambers USA: America’s Leading Lawyers for Business noted that Beni “wins plaudits for his brilliance as a practitioner” and is “a growing presence in the legal community.” Chambers also reported that sources compliment his “amazing command of the law,” which “is blended with practical consideration of what drives business.” The Legal 500 has also ranked Beni in categories, including technology transactions, healthcare and life sciences, and patent licensing (Tier 1).
Experience
Some of Beni’s other representative clients have included Acasti Pharma, Adelson Medical Research Foundation, Alameda Health, Apotex Pharmaceuticals, Aviation Corporation of China (AVIC), BAE Systems, BD Biosciences, Beckman Coulter, Biocept, Blue Cross Blue Shield, Broadcom, Cambrian Biopharma, Children’s Healthcare of Atlanta, Cooper Pharma, Daiichi Sankyo, Dompé Farmaceutici, EV Biologics, Excelra, FluGen, Genomics Institute of the Novartis Research Foundation, iHealth Lab, J. Craig Venter Institute, Jenny Craig, Lacerta Therapeutics, Lashify, Leidos, Lupin Pharmaceuticals, McKesson, Morningside Technology Ventures, Memorial Sloan Kettering Cancer Center, Next Proteins, OnQuality Pharmaceuticals, Organovo, Overland Pharmaceuticals, Reflexion Health, Rezatec, Robin Healthcare, SAIC, SecurityPoint Media, Snap, Therapeutics Inc., Therapeutics MD, and Thermo Fisher Scientific.
Professional Experience
Beni started his legal career at Norton Rose in London. Prior to joining Goodwin, he headed the global technology, intellectual property, and commercial transactions group at another international law firm, and most recently was a partner at Foley & Larder. He also previously resided in the UK, Brazil, and Israel.
Credentials
Education
JD
University of Cambridge
Jesus College
MA
University of Oxford
St. Edmund Hall
BA
University of Oxford
Admissions
Bars
- California
- District of Columbia
- England & Wales
Recognition & Awards
- Selected to the 2023 Top 50 Lawyers In America list by America’s Top Lawyers
- The Legal 500 for ERISA litigation, large M&A deals ($1bn+), technology transactions, M&A deals (venture capital and emerging companies), technology in both outsourcing and data protection and privacy, healthcare and life sciences, and patent licensing (Tier 1)
- Voted Global Technology Transactions Expert of the Year in California by The Lawyer Network
- Voted Technology Licensing Lawyer of the Year in California by Corporate INTL Global Awards
- Chambers USA: America’s Leading Lawyers for Business notes that Beni “wins plaudits for his brilliance as a practitioner” and is “a growing presence in the legal community.” Chambers also notes that “sources compliment his ‘amazing command of the law,’ which ‘is blended with practical consideration of what drives business.’”
- Southern California Super Lawyers®
- Voted Best of the Bar by the San Diego Business Journal
- Winner of the Finance Monthly Deal Maker of the Year Award
- Voted one of the Best Lawyers in San Diego by LegalForce
- Voted San Diego Top Attorney by the Daily Transcript for IP Transactional and Corporate Transactional
Publications
Beni regularly speaks, authors, and teaches on a variety of technology transfer and collaboration-related topics, covering the most recent business strategies, legal debates, challenges, and solutions on maximizing value and revenue from intellectual property both in the US and globally.